Clinical trials
Phase 2 Nervous System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 6 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 8 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 43 |
| Recruiting | 12 |
| Terminated | 10 |
| Withdrawn | 6 |
| Unknown status | 4 |
| Suspended | 2 |
| Enrolling by invitation | 2 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| MapLight Therapeutics | 4 |
| Alkahest, Inc. | 3 |
| Inmune Bio, Inc. | 3 |
| Neuroscience Trials Australia | 3 |
| Northwestern University | 3 |
| U.S. Army Medical Research and Development Command | 3 |
| Flex Pharma, Inc. | 2 |
| GlaxoSmithKline | 2 |
| Knopp Biosciences | 2 |
| Novartis | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nervous System Diseases | 81 |
| Central Nervous System Diseases | 41 |
| Brain Diseases | 36 |
| Neurodegenerative Diseases | 27 |
| Mental Disorders | 24 |
| Dementia | 18 |
| Alzheimer Disease | 16 |
| Neurocognitive Disorders | 13 |
| Neurologic Manifestations | 11 |
| Cognitive Dysfunction | 9 |
Trials
Showing 51 to 75 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.